(S (NP (JJ Clinical) (NN NLP)) (VP (VBZ has) (NP (NP (DT an) (JJ immense) (NN potential)) (PP (IN in) (S (VP (VBG contributing) (PP (IN to) (SBAR (WHADVP (WRB how)) (S (NP (JJ clinical) (NN practice)) (VP (MD will) (VP (VB be) (VP (VBN revolutionized) (PP (IN by) (NP (NP (DT the) (NN advent)) (PP (IN of) (NP (NP (JJ large) (NN scale) (NN processing)) (PP (IN of) (NP (JJ clinical) (NNS records)))))))))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (DT this) (NN potential)) (VP (VBZ has) (VP (VBN remained) (NP (RB largely) (JJ untapped)) (PP (IN due) (IN to) (NP (NP (JJ slow) (NN progress)) (VP (ADVP (RB primarily)) (VBN caused) (PP (IN by) (NP (JJ strict) (NML (NNS data) (NN access)) (NNS policies))) (PP (IN for) (NP (NNS researchers)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP discuss) (NP (NP (NP (DT the) (NN concern)) (PP (IN for) (NP (NN privacy)))) (CC and) (NP (NP (DT the) (NNS measures)) (SBAR (S (NP (PRP it)) (VP (VBZ entails))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBP suggest) (NP (NP (NNS sources)) (PP (IN of) (NP (ADJP (RBR less) (JJ sensitive)) (NNS data))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VBP draw) (NP (NN attention)) (PP (IN to) (NP (NP (NNS biases)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VP (VB compromise) (NP (NP (DT the) (NN validity)) (PP (IN of) (NP (JJ empirical) (NN research))))) (CC and) (VP (VB lead) (PP (IN to) (NP (ADJP (RB socially) (JJ harmful)) (NNS applications))))))))))) (. .))
